Clinical Trials Logo

Bile Duct Neoplasms clinical trials

View clinical trials related to Bile Duct Neoplasms.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT00624182 Suspended - Bile Duct Cancer Clinical Trials

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Start date: February 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and immune response of different doses of URLC10 peptide emulsified with Montanide ISA51 in combination with gemcitabine. Recommended phase II dose will be also determined.